130 related articles for article (PubMed ID: 2784774)
1. Controlled study of different sclerosing agents for coagulation of canine gut arteries.
Randall GM; Jensen DM; Hirabayashi K; Machicado GA
Gastroenterology; 1989 May; 96(5 Pt 1):1274-81. PubMed ID: 2784774
[TBL] [Abstract][Full Text] [Related]
2. Experimental studies of injection therapy for severe nonvariceal bleeding in dogs.
Rutgeerts P; Geboes K; Vantrappen G
Gastroenterology; 1989 Sep; 97(3):610-21. PubMed ID: 2787767
[TBL] [Abstract][Full Text] [Related]
3. Treatment of telangiectasia: comparison of sclerosing agents.
Carlin MC; Ratz JL
J Dermatol Surg Oncol; 1987 Nov; 13(11):1181-4. PubMed ID: 3312331
[TBL] [Abstract][Full Text] [Related]
4. Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents.
Bhargava DK; Singh B; Dogra R; Dasarathy S; Sharma MP
Am J Gastroenterol; 1992 Feb; 87(2):182-6. PubMed ID: 1734694
[TBL] [Abstract][Full Text] [Related]
5. The Australian polidocanol (aethoxysklerol) study. Results at 2 years.
Conrad P; Malouf GM; Stacey MC
Dermatol Surg; 1995 Apr; 21(4):334-6; discussion 337-8. PubMed ID: 7728486
[TBL] [Abstract][Full Text] [Related]
6. Sclerotherapy for leg telangiectasia--a blinded comparative trial of polidocanol and hypertonic saline.
McCoy S; Evans A; Spurrier N
Dermatol Surg; 1999 May; 25(5):381-5; discussion 385-6. PubMed ID: 10469077
[TBL] [Abstract][Full Text] [Related]
7. Effect of hemostatic agents in canine gastric serosal blood vessels.
Whittle TJ; Sugawa C; Lucas CE; Ledgerwood AM; Guan Z; Grabow DE; Nakamura R; Raval M
Gastrointest Endosc; 1991; 37(3):305-9. PubMed ID: 2070979
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic injection therapy.
Bhandarkar DS
Gut; 1993 Aug; 34(8):1150. PubMed ID: 8174973
[No Abstract] [Full Text] [Related]
9. Injection snoreplasty: investigation of alternative sclerotherapy agents.
Brietzke SE; Mair EA
Otolaryngol Head Neck Surg; 2004 Jan; 130(1):47-57. PubMed ID: 14726910
[TBL] [Abstract][Full Text] [Related]
10. Is endoscopic paravascular injection of sclerosing agents reasonable in the control of GI bleeding?
Tatemichi M; Nagata H; Sekizuka E; Morishita T; Mizuki A; Ishii H
Gastrointest Endosc; 1999 Oct; 50(4):499-505. PubMed ID: 10502170
[TBL] [Abstract][Full Text] [Related]
11. Polidocanol injection decreases the bleeding rate after colon polypectomy: a propensity score analysis.
Facciorusso A; Di Maso M; Antonino M; Del Prete V; Panella C; Barone M; Muscatiello N
Gastrointest Endosc; 2015 Aug; 82(2):350-358.e2. PubMed ID: 25910664
[TBL] [Abstract][Full Text] [Related]
12. Human saphenous vein in vitro model for studying the action of sclerosing solutions.
Rotter SM; Weiss RA
J Dermatol Surg Oncol; 1993 Jan; 19(1):59-62. PubMed ID: 8454788
[TBL] [Abstract][Full Text] [Related]
13. Experimental studies of injection agents for peptic ulcer bleeding endoscopic control.
Pundzius J; Jievaltas M
Int Surg; 1998; 83(4):280-2. PubMed ID: 10096741
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing agents in the treatment of telangiectasia. Comparison of the clinical and histologic effects of intravascular polidocanol, sodium tetradecyl sulfate, and hypertonic saline in the dorsal rabbit ear vein model.
Goldman MP; Kaplan RP; Oki LN; Cavender PA; Strick RA; Bennett RG
Arch Dermatol; 1987 Sep; 123(9):1196-201. PubMed ID: 3632004
[TBL] [Abstract][Full Text] [Related]
15. Hyperosmolar versus detergent sclerosing agents in sclerotherapy. Effect on distal vessel obliteration.
Sadick NS
J Dermatol Surg Oncol; 1994 May; 20(5):313-6. PubMed ID: 8176042
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
Ravi M; Kate V; Ananthakrishnan N
Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
[TBL] [Abstract][Full Text] [Related]
17. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
Uncu H
Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
[TBL] [Abstract][Full Text] [Related]
18. Incidence of side effects in the treatment of telangiectasias by compression sclerotherapy: hypertonic saline vs. polidocanol.
Weiss RA; Weiss MA
J Dermatol Surg Oncol; 1990 Sep; 16(9):800-4. PubMed ID: 2398199
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of local sclerosing agents on hemostasis of hepatic bleeding.
Aysan E; Basak F; Kinaci E; Tutuncu H
Hepatogastroenterology; 2007 Jun; 54(76):1212-5. PubMed ID: 17629072
[TBL] [Abstract][Full Text] [Related]
20. Treatment of reticular and telangiectatic leg veins: double-blind, prospective comparative trial of polidocanol and hypertonic saline.
Peterson JD; Goldman MP; Weiss RA; Duffy DM; Fabi SG; Weiss MA; Guiha I
Dermatol Surg; 2012 Aug; 38(8):1322-30. PubMed ID: 22620717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
